322 related articles for article (PubMed ID: 26880659)
1. The role of stem cells in the prevention and treatment of radiation-induced xerostomia in patients with head and neck cancer.
Nevens D; Nuyts S
Cancer Med; 2016 Jun; 5(6):1147-53. PubMed ID: 26880659
[TBL] [Abstract][Full Text] [Related]
2. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
[TBL] [Abstract][Full Text] [Related]
3. The prevention and treatment of radiotherapy - induced xerostomia.
Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced xerostomia in patients with head and neck cancer: a literature review.
Dirix P; Nuyts S; Van den Bogaert W
Cancer; 2006 Dec; 107(11):2525-34. PubMed ID: 17078052
[TBL] [Abstract][Full Text] [Related]
5. [Current status of prevention and management of radiation-induced xerostomia].
Ma DY; Qiu WL; Zhang CP
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Feb; 45(2):121-3. PubMed ID: 20368009
[No Abstract] [Full Text] [Related]
6. Salivary gland sparing in the treatment of head and neck cancer.
Scrimger R
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology and management of radiation-induced xerostomia.
Berk LB; Shivnani AT; Small W
J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
[TBL] [Abstract][Full Text] [Related]
8. Questionable validity of the systematic review and meta-analysis by Lovelace et al. on management of radiotherapy-induced salivary hypofunction and xerostomia in patients with oral or head and neck cancer.
Mercadante V; Lodi G; Porter S; Fedele S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):120-1. PubMed ID: 25482550
[No Abstract] [Full Text] [Related]
9. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction.
Blitzer GC; Rogus-Pulia NM; Mattison RJ; Varghese T; Ganz O; Chappell R; Galipeau J; McDowell KA; Meyers RO; Glazer TA; Kimple RJ
Cytotherapy; 2022 May; 24(5):534-543. PubMed ID: 35183442
[TBL] [Abstract][Full Text] [Related]
10. Stem cells and the repair of radiation-induced salivary gland damage.
Coppes RP; Stokman MA
Oral Dis; 2011 Mar; 17(2):143-53. PubMed ID: 20796229
[TBL] [Abstract][Full Text] [Related]
11. Preserved salivary output and xerostomia-related quality of life in head and neck cancer patients receiving parotid-sparing radiotherapy.
Henson BS; Inglehart MR; Eisbruch A; Ship JA
Oral Oncol; 2001 Jan; 37(1):84-93. PubMed ID: 11120488
[TBL] [Abstract][Full Text] [Related]
12. Xerostomia prevention after head and neck cancer treatment.
Seikaly H
Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):250-1. PubMed ID: 12578460
[No Abstract] [Full Text] [Related]
13. Current ideas to reduce or salvage radiation damage to salivary glands.
Vissink A; van Luijk P; Langendijk JA; Coppes RP
Oral Dis; 2015 Jan; 21(1):e1-10. PubMed ID: 24581290
[TBL] [Abstract][Full Text] [Related]
14. [Research advances in prevention of radiation induced xerostomia by intensity-modulated radiation therapy].
Yan C; Wang ZH
Shanghai Kou Qiang Yi Xue; 2008 Oct; 17(5):540-4. PubMed ID: 18989600
[TBL] [Abstract][Full Text] [Related]
15. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review.
Lovelace TL; Fox NF; Sood AJ; Nguyen SA; Day TA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 May; 117(5):595-607. PubMed ID: 24650370
[TBL] [Abstract][Full Text] [Related]
16. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
Jensen SB; Vissink A; Limesand KH; Reyland ME
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425600
[TBL] [Abstract][Full Text] [Related]
17. Clinical commentary on prophylactic treatment of radiation-induced xerostomia.
Chambers MS
Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):251-2. PubMed ID: 12578461
[No Abstract] [Full Text] [Related]
18. Influence of parotid-sparing radiotherapy on xerostomia in head and neck cancer patients.
Malouf JG; Aragon C; Henson BS; Eisbruch A; Ship JA
Cancer Detect Prev; 2003; 27(4):305-10. PubMed ID: 12893079
[TBL] [Abstract][Full Text] [Related]
19. Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia.
Blitzer GC; Paz C; Glassey A; Ganz OR; Giri J; Pennati A; Meyers RO; Bates AM; Nickel KP; Weiss M; Morris ZS; Mattison RJ; McDowell KA; Croxford E; Chappell RJ; Glazer TA; Rogus-Pulia NM; Galipeau J; Kimple RJ
Radiother Oncol; 2024 Mar; 192():110093. PubMed ID: 38224919
[TBL] [Abstract][Full Text] [Related]
20. Management of salivary hypofunction during and after radiotherapy.
Shiboski CH; Hodgson TA; Ship JA; Schiødt M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
